TG THERAPEUTICS, INC. (TGTX)
Pharmaceutical Preparations · Healthcare · $7.7B
Intrinsic Value (Consensus)
$32.84
Current Price
$50.54
Margin of Safety
-35%
35% Above Intrinsic Value
Value: $33
Price: $51
Valuation Model Estimates
Current Price: $50.54
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$16.24
Earnings Power Value
$26.89
Relative Value (P/E)
$55.40
Dividend Discount Model
Not applicable
—
Consensus Value
$32.84
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
68
Profitability
25/25
Strength
14/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Negative free cash flow — company is burning cash
Strong profitability — ROE of 69% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $2.77
- EPS (Forward)
- $3.32
- Book Value
- $4.23
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 69.0%
- Debt/Equity
- 15%
- Revenue Growth
- 87.3%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance